ARNA - No guts. Not glory. To all long time longs.
I have been in and out of ARNA since 2005. It has been a joy and a pain. Last year I sold in the $6 range before AdCom and have been buying all year long in the $1.50 range. This time I am holding. No guts. No glory.
One can imagine the value of this company and its patent portfolio in treating a broad range of diseases from obesity to diabetes to smoking.
We have all been patient and our day has come. ARNA will graduate from a micro pharma company to a pharma company instantly. It will be acquired in 2 years for $10 billion.
Mega pharmas have a huge void to fill and are hungry for new drugs. Drugs are not coming out as frequently as they used to. There has been an intellectual pit over the past 5 years. Development of novel therapies has come to a halt in part due to oppressive governmental policies that stifel innovation through bureaucratic minefield. In addition, costs of bringing a drug to market have sky-rocketed. ARNA spent almost $500 million already only to be shafted in 2010. Lastly, major drugs are coming off patent protection leaving mega pharmas to compete with generic equivalents.
I repeat. ARNA will be acquired within 2 years for an absolutely huge premium. So quit splitting pennies and realize that you are in at the bottom of what's surely to become a mountain.
Good luck everyone! Long and strong. Holding for the buyout.